This research presentation will cover the development of targeted protein degraders, including PROTACs and molecular glues, and covalent inhibitors through chemoproteomics.

Vaccine immunotherapy targeting fentanyl (FEN) may address the rising incidence of opioid use disorder (OUD) and overdose deaths, where current treatments fall short.